CN104784501A

CN104784501A - Medicament for treating migraine

Info

Publication number: CN104784501A
Application number: CN201510240784.XA
Authority: CN
Inventors: 潘连香
Original assignee: Individual
Current assignee: Individual
Priority date: 2015-05-12
Filing date: 2015-05-12
Publication date: 2015-07-22

Abstract

The invention relates to a medicament for treating migraine. The medicament is prepared from the following components in parts by weight: 350 parts of kyllinga monocephala, 320 parts of Scfhisandra bicolor Cheng., 300 parts of tongking pepper, 300 parts of Radix Osterici Grosseserrati, 280 parts of Leontopodium wilsonii Beauvd., 260 parts of Pteridium revolutum (Bl.)Nakai, 250 parts of Paphiopedilum concolor, 270 parts of Ampelopsis grossedentata, 250 parts of salvia chinensis, 260 parts of gardenia, 230 parts of narrowleaf fig roots and leaves, 210 parts of Saxifraga pasumensis Marq. etShaw. f. integrifolia Jeeir, 180 parts of gmelin sealavender herb, 200 parts of Indian lettuces, 170 parts of Dicliptera chinensis and 150 parts of liquorice. All components of the medicament for treating migraine provided by the invention are natural materials, so that the medicament is relatively good in safety and suitable for clinically large-scale popularization.

Description

One treats migrainous medicament

Technical field

The present invention relates to field of medicaments, relate in particular to one and treat migrainous medicament.

Background technology

Migraine mostly is the pulsatile headache of one or both sides temples recurrent exerbation, can accompany vision, somatosensor aura before outbreak, and outbreak accompanies vomiting often; Women is multiple, is about 3 ~ 4 times of male, and how in adolescence onset, age of onset 25 ~ 34 years old, the childhood period that minority betiding or after the middle age.Cause the migrainous cause of disease a lot, heredity, Endocrine and metabolism factor, diet and medicine, Nervous and Mental Factors etc. can cause migraine, bring no small difficulty because the state of an illness is complicated to treatment.

Existing technology, many employings Western medicine analgesic method, this Therapeutic Method can only play the effect taken stopgap measures, alleviate the puzzlement of headache, can not be tackled the problem at its root easy recurrent exerbation, long-term taking analgesic can cause serious drug dependence toward contact, causes serious wrecking to patient's body and mind.

Summary of the invention

The object of this invention is to provide one and treat migrainous medicament.

In order to realize object of the present invention; the invention provides one and treat migrainous medicament, it is made up of the material of following weight proportioning: Herba Kylligac coloratae 350 parts, Radix Schisandrae Bicoloris 320 parts, Herba Piperris Tonkinensis 300 parts, scenery with hills and waters Herba Apii graveolentis 300 parts, Leontopodium wilsonii Beauv. 280 parts, Herba Fimbristylis dichotomae 260 parts, Philippine Paphiopedilum (Concolor Paphiopedilum) 250 parts, Ampelopsis cantoniensis （Hook. et Arn.） Planch. var. grossedentata Hand.-Mazz. 270 parts, Herba Salviae Chinensis 250 parts, Flos micheliae Albae 260 parts, Radix Fici Angustipoliae 230 parts, pectinate rockfoil 210 parts, Herba Limonii Gmelinii 180 parts, Herba Ixeritis Denticulatae 200 parts, Herba Diclipterae Chinensis 170 parts and 150 parts, Radix Glycyrrhizae.

Preferably, described medicament is tablet, dispersible tablet, capsule or decoction.

In the present compositions; Herba Kylligac coloratae, Radix Schisandrae Bicoloris are monarch drug; Herba Piperris Tonkinensis, scenery with hills and waters Herba Apii graveolentis, Leontopodium wilsonii Beauv., Herba Fimbristylis dichotomae, Philippine Paphiopedilum (Concolor Paphiopedilum) are ministerial drug; Ampelopsis cantoniensis （Hook. et Arn.） Planch. var. grossedentata Hand.-Mazz., Herba Salviae Chinensis, Flos micheliae Albae, Radix Fici Angustipoliae, pectinate rockfoil, Herba Limonii Gmelinii, Herba Ixeritis Denticulatae, Herba Diclipterae Chinensis are adjuvant drug; Radix Glycyrrhizae coordinating the actions of various ingredients in a prescription, for making medicine.

Preferably, medicament of the present invention can be tablet, dispersible tablet, capsule or decoction.Method well known to those skilled in the art can be adopted to carry out the preparation of medicament.As required, various pharmaceutically acceptable carrier can be added.Described carrier comprises the diluent, excipient, filler, binding agent, wetting agent, disintegrating agent, absorption enhancer, surfactant, absorption carrier, lubricant etc. of pharmaceutical field routine.In the preparation, selectable filler has medicament of the present invention: starch, Icing Sugar, calcium phosphate, dextrin, microcrystalline Cellulose, lactose, pregelatinized Starch, mannitol etc.; Selectable binding agent has: sodium carboxymethyl cellulose, PVP-K30, hydroxypropyl cellulose, starch slurry, methylcellulose, ethyl cellulose, hydroxypropyl emthylcellulose, gelling starch etc.; Selectable disintegrating agent has: dried starch, polyvinylpolypyrrolidone, cross-linking sodium carboxymethyl cellulose, carboxymethyl starch sodium, low-substituted hydroxypropyl cellulose etc.; Selectable lubricant has: magnesium stearate, Pulvis Talci, sodium lauryl sulphate, micropowder silica gel etc.

Whole compositions of the migrainous medicament for the treatment of of the present invention are all natural materials, and safety is better, is suitable for large-scale promotion clinically.

Detailed description of the invention

The present invention is further illustrated below by embodiment.It should be understood that embodiments of the invention are for illustration of the present invention instead of limitation of the present invention.Essence according to the present invention all belongs to the scope of protection of present invention to the simple modifications that the present invention carries out.Unless otherwise stated, the percent in the present invention is percetage by weight.

Embodiment

Take Herba Kylligac coloratae 350 grams, Radix Schisandrae Bicoloris 320 grams, Herba Piperris Tonkinensis 300 grams, scenery with hills and waters Herba Apii graveolentis 300 grams, Leontopodium wilsonii Beauv. 280 grams, Herba Fimbristylis dichotomae 260 grams, Philippine Paphiopedilum (Concolor Paphiopedilum) 250 grams, Ampelopsis cantoniensis （Hook. et Arn.） Planch. var. grossedentata Hand.-Mazz. 270 grams, Herba Salviae Chinensis 250 grams, Flos micheliae Albae 260 grams, Radix Fici Angustipoliae 230 grams, pectinate rockfoil 210 grams, Herba Limonii Gmelinii 180 grams, Herba Ixeritis Denticulatae 200 grams, Herba Diclipterae Chinensis 170 grams and 150 grams, Radix Glycyrrhizae, pulverize, cross 100 mesh sieves, then Icing Sugar 250 grams is taken, cross 80 mesh sieves, mix with above-mentioned raw materials, binding agent soft material is made with the HPMC aqueous solution of 3 % by weight, granulate by 16 order nylon mesh, drying 3 hours at 70 DEG C, with 16 object nylon mesh granulate, add the carboxymethyl starch sodium of 430 grams and the magnesium stearate of 120 grams again, mixing, with the drift tabletting 1000 of diameter 14mm, obtain.

Experimental example

Diagnostic criteria

The headache classification that migraine Western medicine diagnose standard is formulated with reference to " migraine diagnosis and treatment Consensus of experts " and diagnostic criteria (migraine diagnosis and treatment Consensus of experts group. migraine diagnosis and treatment Consensus of experts [J] CHINESE JOURNAL OF INTERNAL MEDICINE, 2006,45 (8); 694-696.) draft and " traditional Chinese medical science Clinical Researches of New Drugs guideline " headache diagnoses standard (Zheng Xiao cornel. traditional Chinese medical science Clinical Researches of New Drugs guideline [S]. Beijing: China Medical Science Press, 2002; 105-109.) draft: (1) migraine with psychentonia, physical fatigue, emotional factor, environmental stimuli, menstrual onset, environment change etc. for inducement; (2) headache show as paroxysmal outbreak inclined side throbbing pain, dusk pain, distending pain etc., the persistent period be several minutes or a few hours not etc., be generally no more than 24h, occasionally last up to 1 week person, intermission, as ordinary person, falls ill again through an intersegmental after date of having a rest, the course of disease many delay several years; (3) Nausea and vomiting, tinnitus or insomnia, the symptom such as vexed can be accompanied during migraine; (4) physico-chemical examination such as nervous system is without special.

Choose patient 100 example meeting above-mentioned standard, wherein man 20 example, female 80 example, the age is 26 years old-37 years old, 33 years old mean age, average course of disease half a year.Complete inspection routine blood test, rheoencephalogram before all patients treatment, part checks electroencephalogram, brain mapping, and severe one makes head CT and MRI checks.

Therapeutic Method

Prepare tablet in use embodiment above-mentioned patient is treated, three times on the one, each oral a slice.Be a course for the treatment of with 15 days, carry out two courses for the treatment of continuously.

Criterion of therapeutical effect

Recovery from illness: headache and simultaneous phenomenon disappear, follow up a case by regular visits to 6 months without recurrence, rheoencephalogram is normal;

Effective: headache and simultaneous phenomenon disappear, and follow up a case by regular visits to and have rebound phenomenon in 6 months, rheoencephalogram is substantially normal;

Take a turn for the better: Headache attacks degree and simultaneous phenomenon alleviate, and rheoencephalogram is improved;

Invalid: to treat after 2 courses for the treatment of headache and simultaneous phenomenon without improvement.

Result

Through treatment, find that the headache of all patients and simultaneous phenomenon disappear, follow up a case by regular visits to 6 months without recurrence, rheoencephalogram is normal, therefore all meets recovery from illness standard, and does not find obvious untoward reaction in therapeutic process.

Claims

1. the migrainous medicament for the treatment of; it is characterized in that, it is made up of the material of following weight proportioning: Herba Kylligac coloratae 350 parts, Radix Schisandrae Bicoloris 320 parts, Herba Piperris Tonkinensis 300 parts, scenery with hills and waters Herba Apii graveolentis 300 parts, Leontopodium wilsonii Beauv. 280 parts, Herba Fimbristylis dichotomae 260 parts, Philippine Paphiopedilum (Concolor Paphiopedilum) 250 parts, Ampelopsis cantoniensis （Hook. et Arn.） Planch. var. grossedentata Hand.-Mazz. 270 parts, Herba Salviae Chinensis 250 parts, Flos micheliae Albae 260 parts, Radix Fici Angustipoliae 230 parts, pectinate rockfoil 210 parts, Herba Limonii Gmelinii 180 parts, Herba Ixeritis Denticulatae 200 parts, Herba Diclipterae Chinensis 170 parts and 150 parts, Radix Glycyrrhizae.

2. the migrainous medicament for the treatment of according to claim 1, is characterized in that, described medicament is tablet, dispersible tablet, capsule or decoction.